RH Bophelo

Quinton Zunga is the founder, CEO, and executive director. He previously co-founded Arkein Capital Partners and spent over a decade in senior investment banking roles. The board includes non-executive directors with healthcare operations and asset management backgrounds, but the firm’s website identifies Zunga as the lead executive on strategy execution. Day-to-day financial oversight sits with CFO Yondie Metu, appointed December 2023.

It is a publicly listed investment holding company, not a closed-end fund. RH Bophelo listed on the JSE in 2017 and later on the Rwanda Stock Exchange. Because it trades as an equity, it offers daily liquidity to shareholders while pursuing a private equity-style strategy of acquiring and consolidating healthcare operating businesses.

The firm describes itself as pan-African and holds a secondary listing on the Rwanda Stock Exchange. All eight disclosed acquisitions to date are South African hospitals, a nursing college, a pharmacy, and an insurance underwriter. No specific investments outside South Africa have been publicly announced, though the dual listing and stated mandate signal intent.

The firm targets entry-level hospitals, specialized services hospitals, and businesses that sit in the gap between South Africa’s public and high-end private sectors. Beyond inpatient facilities, it has acquired an insurance underwriting business and a nursing college to build a vertically integrated ecosystem. The stated focus is lower- to middle-income populations that are underserved by existing infrastructure.

In September 2019, the firm acquired Genric, a short-term underwriter. The logic, as stated on the firm’s own website, is to facilitate access for the uninsured population — creating a pathway for patients who fall outside traditional medical aid coverage to still receive care within the RH Bophelo hospital network. It turns the insurance vehicle into a patient-feed system for the group’s facilities.

The firm’s website lists Razorite Healthcare and RH Managers as linked entities, but does not provide detailed ownership or operational mapping. The links appear in the site footer alongside standard investor relations pages. Additional disclosure on their specific roles is not available from the firm’s public materials.

Dr. Phetole David Sekete, a non-executive director, has 33 years of medical experience across public and private hospitals and has run a private practice for 30 years. Colin Clarke, the chairman, chairs the Investment Committee of Sizwe Medical Fund. Non-executive director Carmen Mpelwane has sector coverage experience in healthcare as a listed-equity portfolio manager.